These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6319516)

  • 1. Measurement of low angiotensin concentrations after ethanol and Dowex extraction procedures.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Lab Clin Med; 1984 Feb; 103(2):304-12. PubMed ID: 6319516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma angiotensins under sustained converting enzyme inhibition with enalapril in normal humans.
    Nussberger J; Brunner DB; Waeber B; Brunner HR
    J Hypertens Suppl; 1985 Dec; 3(3):S269-70. PubMed ID: 2856820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
    Wilkes BM
    J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension.
    Jackson B; McGrath BP; Johnston CI
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():99-104. PubMed ID: 6291832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
    Sweet CS
    Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CGS 13945: a new orally active angiotensin-converting enzyme inhibitor in normal volunteers.
    Jacot des Combes B; Turini GA; Brunner HR; Porchet M; Chen DS; Sen S
    J Cardiovasc Pharmacol; 1983; 5(4):511-6. PubMed ID: 6193344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic and hormonal effects of MK-521 in congestive heart failure.
    Dickstein K; Aarsland T; Woie L; Kremer D; Abrahamsen AM
    Scand J Urol Nephrol Suppl; 1984; 79():125-7. PubMed ID: 6089311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
    Ahmad M; White R; Tan J; Huang BS; Leenen FH
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma angiotensins and blood pressure during converting enzyme inhibition.
    Mento PF; Wilkes BM
    Hypertension; 1987 Jun; 9(6 Pt 2):III42-8. PubMed ID: 3036705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin vs. angiotensin-converting enzyme inhibition in the rat: consequences for plasma and renal tissue angiotensin.
    Allan DR; Hui KY; Coletti C; Hollenberg NK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):661-5. PubMed ID: 9353383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of enalapril on plasma Ang II level and the expression of AT1 in blood vessel and kidney of type 2 diabetic rats].
    Yang J; Xue C; Hu G
    Yao Xue Xue Bao; 2005 Mar; 40(3):208-12. PubMed ID: 15952590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F; Kuru O; Sentürk UK
    Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in angiotensinogen and des-angiotensin I-angiotensinogen in man and rat upon inhibition of converting enzyme].
    Clauser E; Genain C; Bouhnik J; Corvol P; Ménard J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():157-61. PubMed ID: 6287956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
    Biollaz J; Schelling JL; Jacot Des Combes B; Brunner DB; Desponds G; Brunner HR; Ulm EH; Hichens M; Gomez HJ
    Br J Clin Pharmacol; 1982 Sep; 14(3):363-8. PubMed ID: 6289859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.